Board of Directors

Members of the Board of Directors (BoD):

Four BoD and Executive Council Members  (in alphabetical order):

President: Prof. Aiping Lu

Aiping Lu
Aiping Lu

Professor Lu Aiping is Chair Professor & Dean of School of Chinese Medicine, Hong Kong Baptist University, and Chair Professor in Shanghai University of Traditional Chinese Medicine. Prof. Lu is also the recipient of the Distinguished Young Scholar in National Science Foundation of China (NSFC) in 2007. Besides, he also as Member of Medical Advisory Committee of National Natural Science Foundation of China (NSFC), Member of Chinese Pharmacopoeia Commission and Vice-Chairman, Terminology of Traditional Chinese Medicine Sub-Committee, China National Committee for Terms in Sciences and Technologies (CNCTST). Also he has been appointed as Head & Spokesperson of the China Delegation, International Organization for Standardization Technical Committee on TCM (ISO/TC249) since 2009. His research interests mainly focus on the translational research in Chinese medicine, including pharmacological and clinical evaluation on rheumatoid arthritis with traditional Chinese medicine pattern diagnosis and interventions, and development of new drugs based on Chinese medicines. Also he is actively involving the research on the standardization of Chinese medicine and strategic plan research for Chinese medicine development in China. Prof Lu has published more than 30 books and over 500 articles, including 200 articles in SCI journals such as Nature Medicine, Nature Communication, Biomaterials, and Briefings in Bioinformatics.

Return to top

Treasurer and Past President: Dr. Tai-Ping Fan

Tai-Ping Fan
Tai-Ping Fan

Born in Taiwan, I received my PhD from University of London and moved to University of Cambridge in 1986. Capitalizing on my immunopharmacology background, I set up Angiogenesis & Chinese Medicine Laboratory and embarked on a quest to transform the art of TCM into a rigorous evidence-based science of healthcare. From clinically effective herbs, we have been investigating the cellular and molecular mechanisms of their compounds in the prevention and treatment of angiogenic diseases e.g. cancer, diabetic retinopathy and chronic wounds. With an international team of researchers from the US, the Netherlands and Hong Kong, we were the first to report in Circulation (2004) that the differential effects of ginseng on vascular pathophysiology was due to the specific make-up of pro- and anti-angiogenic ginsenosides in different types of ginseng. Working closely with research institutes, pharmaceutical companies, philanthropists and government agencies, I aspire to create a Cambridge Centre of Ethnopharmacology and Natural Medicine for promoting international collaborations of TCM and other traditional medicines.

My outreach activities include
▪     AAAS Science magazine Special Supplement on ”The Art and Science of Traditional Medicine” (4 parts)
▪     A speech “Health and Healing Through Evidence-based Applications of Traditional Medicine” at United Nations Headquarters in July 2015

Return to top

Past Treasurer: Prof. Peter John Hylands (1946-2019)

Peter John Hylands

Professor Hylands is a pharmaceutical chemist and started his career with academic appointments in the University of Strasbourg, as a Royal Society European Fellow, and in the University of London.  His special research interest has always been natural products in medicine.  He joined the commercial world in 1988 as Director of Chemistry and then Research Director of biopharmaceutical companies in the UK and the USA.  He has consulted for the United Nations and Commonwealth Science Council.  He has worked or collaborated with institutions on every continent in natural medicines and natural product research and development.  He serves on a number of boards and advisory boards and is currently Head of the Department of Pharmacy, King’s College London and Joint Head of the Institute of Pharmaceutical Science, King’s College London.  He teaches organic chemistry, including the application of spectroscopy to structural studies, and pharmacognosy, for undergraduate and postgraduate courses.  His current research emphasises the application of chemometrics and emerging biotechnologies to the problems of standardisation and quality control of plant medicines.  He now has a research group in the Centre for Natural Medicines Research, King’s College London of which he is Director.
Return to top

Secretary-General: Prof. Clara Bik-San Lau

Clara Lau

Professor Clara Lau is the Associate Director of the Institute of Chinese Medicine at The Chinese University of Hong Kong. She also serves as the Associate Director of the State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants (CUHK), and has a courtesy appointment as Associate Professor at the School of Chinese Medicine, CUHK. With BPharm and PhD in Pharmacy (Pharmacognosy) from King’s College London, University of London, United Kingdom, she has a continuous interest in medicinal plants (western herbals and traditional Chinese medicines) and has over 23 years’ experience in natural products research. Her main research areas include anti-cancer, anti-diabetic, and wound-healing activities of natural products, and has published over 215 refereed journal articles. She currently serves as member of ChP-USP Advisory Group on Monographs for Traditional Chinese Medicine Ingredients and Products; Deputy Secretary General of The Consortium for Globalization of Chinese Medicine (CGCM); Secretary General of Good Practice in Traditional Chinese Medicine Research Association (GP-TCM RA); Associate Chief Executive of Modernized Chinese Medicine International Association (MCMIA); Associate Editor of “Journal of Traditional and Complementary Medicine(eJTCM)” and Editorial Board member of journals “Phytomedicine”, “Scientific Reports”, “Journal of Natural Products” and “Journal of Ethnopharmacology”.

Return to top

President-Elect: Prof. Monique Simmonds

Monique Simmonds

I gained my BSc at Leeds University and PhD from Birkbeck College, University of London. I joined Royal Botanic Gardens, Kew in 1985 working on different aspects of plant/fungal chemistry. I was introduced to Traditional Chinese Medicine in the mid 1990’s by my colleague Dr Christine Leon. I then helped Kew raise funds for the creation of the large collection of TCM at Kew that started in 1998. I was then involved in a range of TCM related projects and was part of the team headed by Dr Qihe Xu (Kings College) that summited the EU-China F7 Network Proposal that was the initial concept for this society. I initially headed the Quality Control Work-package. I have taken an active role in different aspects of the quality control of herbs and was invited to join the International Advisory Committee Materia Medica, Hong Kong and I chair the Herbal Advisory Committee for the UK Pharmacopeia Committee. I work with Prof Clara Lau on joint projects and have academic and commercially funded projects on TCM plants in China. I have over 350 scientific publication. I was awarded an OBE (UK honour) for services to science, the environment, technological innovation and community.

Return to top

Nine BoD Members (in alphabetical order):

Past President: Prof. Rudolf Bauer

Rudi Bauer

Studied pharmacy at University of Munich; Ph.D. in 1984; 1993-2002 associate professor at the Institute of Pharmaceutical Biology, University of Düsseldorf; since 2002 professor of pharmacognosy at University of Graz, Austria; 2004 Head of Institute of Pharmaceutical Sciences at University of Graz; since 2008 head of TCM Research Center Graz – medicinal plant research. Guest professor at School of Chinese Materia Medica, Beijing University of Chinese Medicine; Guangxi Botanical Garden of Medicinal Plants and Institute of Guangxi Medicinal Plants, Nanning; Institute of Medicinal Plant Development, China Academy of Medical Sciences, Beijing; Chengdu University of TCM; Heilongjiang University of CM, Harbin; Changchun University of CM. Recipient of Egon-Stahl-Award of the Society for Medicinal Plant Research (GA); Norman Farnsworth Excellence in Botanical Research Award; Qihuang International Prize of China Association of Chinese Medicine,  Outstanding International Scientist Award (Pranab Banerji Memorial Award) of the Society for Ethnopharmacology India (SFE). Associate Editor in Chief of Chinese Journal of Natural Medicines and World Journal of Traditional Chinese Medicine (WJTCM). Chairman of the expert group on Chinese herbs of the European Pharmacopoeia. Previous president of the Society for Medicinal Plant and Natural Products Research (GA) and of the International Society for Ethnopharmacology (ISE). Long experience in natural product chemistry; ca. 360 scientific publications.

Return to top

Mr. Abraham Chan

Abraham Chan
Abraham Chan

I am the founder and Chairman of PuraPharm Corporation Ltd, a publicly traded company listed on the Main Board of HK Stock Exchange. PuraPharm dedicates itself to the modernization and internationalization of traditional Chinese medicine (TCM) and is a leading company engaged in the R&D, production, marketing and selling of concentrated Chinese Medicine granules(CCMG) products.PuraPharm has been supplying CCMG to the majority of hospitals in Hong Kong since 2004 and is one of the only five, and the only non-PRC company licensed by the CFDA to manufacture and sell CCMG products in China.  PuraPharm is the largest and the leading CCMG manufacturer in Hong Kong, and owns the largest Chinese medicine clinic chain in HK. PuraPharm’s own TCM research & production facilities is based in Guangxi, China which complies with the PRC Good Manufacturing Practice (GMP) standards, as well as Australia’s Therapeutic Goods Administration (TGA) standards. PuraPharm also owns a Chinese herbs plantation site in the province of Guizhou, China, covering an area of over 4,000 acres.
As the founder and the Chairman of the Company and with extensive experience in Chinese medicine and healthcare products, I am responsible for directing the overall strategies and planning of the Group’s business. I also lead the Group’s R&D and technological development functions.  PuraPharm, actively collaborating with various universities and research institutes internationally, has established itself as the technological front-runner within the industry.  Through continuous innovation, PuraPharm has come to be regarded as a leading company in the research and development of traditional Chinese medicine.

Return to top

Prof. Pierre Duez

Pierre Duez

PhD in Pharmaceutical Sciences (Toxicology), Pierre Duez heads a teaching and research department in the Université de Mons (Faculty of Medicine and Pharmacy); he is teaching Pharmacognosy, Pharmacology, Nutrition and bibliographical tools, both in theory and practice. He has access to chromatographic and spectroscopic techniques for Belgian and foreign PhD students. Specialized in the study and analysis of natural products, the team concentrates on the elucidation of DNA repair modulators and on the integration of traditional medicines with African modern medicine (DR Congo). Pierre Duez is member of the European Pharmacopoeia TCM working party, of the European Medicines Agency (Monograph and List Working Party), of the Belgian Commissions of Pharmacopoeia and Registration of Herbal Medicines. He is active in development cooperation with Algeria, Argentina, Germany, Burkina Faso, France, Uganda, UK, DR Congo, PR China, Rwanda, Madagascar, Vietnam. Member of the GP-TCM consortium, he is currently Board Member and Chair of the Pharmacology & Toxicology Interest Group for the GP-TCM RA.  Heis (co-)supervisor of 19 defended theses, co-editor of 1 book, co-author of 8 book chapters, 157scientific papers, 1 report for the European Development Fund, 1 patent and 274 communications in meetings. He has organized the 2015 GP-TCM RA meeting in Mons, Belgium.

Return to top

Prof. Thomas Efferth

Thomas Efferth

Professor Dr. Prof. h. c. mult. Thomas Efferth is chair of the Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany. He is biologist by training (Technical University of Darmstadt, Germany). His doctoral thesis was completed at the German Cancer Research Center (DKFZ), Heidelberg, Germany (1990). Dr. Efferth was awarded the Ludolf-Krehl-Prize of the Southwest German Association for Medicine (1991), the Willmar-Schwabe-Award of the German Society for Medicinal Plant Research (2006), the citizen medal of the City of Heidelberg, Germany (2008), the CESAR Award for Translational Oncology (2011), the SCENTEDdrop Award on medicinal and flagrant herbs (2015), and the QihuangInternational Award of the Chinese Association of Chinese Medicine (2017). Since 2018, he is full member of the World Academy of Sciences.
He headed a research group for Pharmaceutical Biology at DKFZ (2005-2009) and was adjunct professor (apl.) at the University of Heidelberg (2007-2009). In 2009, he took over the Chair of Pharmaceutical Biology (full professorship) at the Johannes Gutenberg University, Mainz. Furthermore, he is honorary professor at the Northeast Forestry University, Harbin, and at the Zhejiang Chinese Medical University, Hangzhou, China. Moreover, he is visiting professor at the Zhejiang University of Science and Technology, Hangzhou, China and honorary adjunct professor at the Chinese University Hong Kong.
Thomas Efferth has published 530 PubMed-listed papers and in peer-reviewed journals in the field of cancer research, pharmacology, and natural products (Hirsch-factor: 73; citation rate: >20,000; acc. Google Scholar)and a textbook on ‘Molecular Pharmacology and Toxicology’ (Springer Publisher; 2006).He holds 7 patents. The scientific results were communicated in over 250 oral presentation and invited lectures and over 180 poster presentations at national and international conferences and meetings. He is editor-in-chief of Phytomedicine as well as co-editor, associate editor and editorial board member of several scientific journals and scientific advisory board member of the German Pharmaceutical Society and several other institutions. Seven of his former lab members promoted to associate or assistant professors.
The focus of Dr. Efferth’s research is on tumor pharmacology, network pharmacology, and the development of novel options for treatment and diagnosis of cancer. A major topic is research on chemical entities from natural sources.

Return to top

Prof. Rong-Rong He

Rong-Rong He

Professor Rong-Rong He is the Director of Guangdong Engineering Research Center of Chinese Medicine & Disease Susceptibility in Jinan University. She also serves as the Associate Director in the Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University. She gained her BPharm and PhD in Pharmacy (Chinese Materia Medica) from Shenyang Pharmaceutical University, Shenyang, China. The effectiveness of herbal medicine has always been difficult to evaluate with conventional pharmacological methods. She focuses on using a variety of stress loaded models for anti-stress research and natural product evaluations and improving the effects on homeostasis and disease prevention. These related research projects are supported by dozens of funding sources such as National Natural Science Foundation. As a young researcher, she has published over 100 scientific articles in peer reviewed journals, presented scientific reports at local, national and international conferences, and is the owner of 6 authorized patents. Dr. He has been awarded with the Guangdong Provincial Science and Technology Progress Award (First Class) and Technological Progress Award from Ministry of Education (Second Class) for her great contribution for the TCM studies.

Return to top

Prof. Rob Verpoorte

Rob Verpoorte

Robert Verpoorte is since May 2011 emeritus professor at the Natural Products Laboratory, Institute Biology Leiden, Leiden University.
Pharmacists degree (1972) and PhD (1976) from Leiden. Lecturer at Leiden University 1976-1987, and since 1987 professor and head of the department of Pharmacognosy. Since 2011 Emeritus professor still connected to Leiden University. Guest professor in London (UK), Uppsala (Sweden), Amiens (France),Reims (France), Seoul (Korea) and Hilo (USA). From 1992-1998 Vice-Chairman and Chairman of the committee of the Phytochemical Society of Europe (PSE). Since May 2011 professor Emeritus at Leiden University. Author/co-author of 780+ scientific papers, 4 books and 6 patent applications. September 2017 H factor 66 (Web of Science), 93 (Google Scholar) 74 (Scopus). Editor (1996-2002) and Editor-in-chief of Journal of Ethnopharmacology (IF 3.115)(2003-2016) and editor-in-chief of Phytochemistry Reviews (IF 3.393) since 2001 and Executive Editor Biotechnology Letters (IF 1.846) since 2006. He supervised 66 PhD-theses, and 150+ MSc theses. Honorary Doctorate University of Amiens, France (2004) and the University of Uppsala, Sweden (2012). In 2007 he received the PSE Medal. Honorary professor at the Hong Kong Baptist University since 2015. In 2015 awarded the Gusi Peace Prize in Manila, The Philippines. September 2017 awarded the Egon Stahl Medal in Gold by the International Society of Medicinal Plants and Natural Products Research for his lifetime scientific work.

Return to top

Prof. Vivian Taam Wong

Vivian Taam Wong

Current Service to Professional Organizations:

  • Hon Professor, School of Chinese Medicine, HKU
  • Vice President, Modernized Chinese Medicine International Association
  • Board of Director, GP-TCM Research Association
  • HK Coordinator, Consortium for Globalization of Chinese Medicine
  • Council Member, Chinese Association of Integrative Medicine
  • Member, International Chinese Medicine Clinical Standards Working Committee, WFCMS

Key Past Appointments:

  • Public Health Specialist, Policy & Research, Population Health & Nutrition, The World Bank
  • Chairman, Committee on Safe Motherhood, International Federation of Gynecology & Obstetrics
  • Member of various Committees under World Health Organization
  • Consultant on Health Project IV & VI in China for the World Bank
  • Chief Executive, Hospital Authority, HK
  • Hon Advisor in Integrative Medicine, Hospital Authority, HK
  • Hon Senior Advisor to Dean of Medical Faculty, the University of HK
  • President, HK Association for Integration Chinese-western Medicine

She has been on editorial boards of 7 journals, and published >130 peer-reviewed papers.She set up the unique HK-wide Research Ethics Committee system & standards enabling multicentre trials as well as the high quality network of Chinese Medicine Centres for Training and Research in each district in HK. She is now steering education, research and knowledge transfer to support collaboration among CM and western medicine practitioners.
Return to top

Dr. Qihe Xu

Qihe Xu

Dr. Qihe Xu, Co-Director of King’s Centre for Integrative Chinese Medicine (CICM), Senior Lecturer in Renal Medicine, Pharmacology Admissions Tutor and Organiser of MSc/MRes Pharmacology Projects at King’s College London (KCL).
In 2009-2012, I coordinated the FP7 GP-TCM Project, which founded in the GP-TCM RA. As a GP-TCM RA Life Member, I have served on the BoD for two terms (Vice President & Vice Secretary-General, 2012-2014 and Newsletter Editor-in-chief, 2017-2018).
Earning my MBBS, MD and PhD and having practised clinically for 10 years in China, I have been devoting myself to research and teaching in the UK since 1999. Particularly passionate about integrating TCM wisdom into tomorrow’s medicine and pharmacology, my research has focused on TCM-inspired studies of kidney health and disease, herbal anti-fibrotics and botanical nephrotoxicity.
My honours include a meritorious medal from the Chinese PLA, a national award for scientific & technological advances in China, a scholarship and a fellowship from the International Society of Nephrology and a Courtesy Associate Fellowship of the US National Institutes of Health. Other experiences include Secretary-General, Chinese Students & Scholars Association in the UK, and President, Chinese Life Scientists Society in the UK.

Return to top

Prof. Min Ye

Min Ye

Prof. Min Ye is a Professor in Pharmacognosy at the School of Pharmaceutical Sciences, Peking University. He is currently Vice Dean of the School of Pharmaceutical Sciences, and Deputy Director for the State Key Laboratory of Natural and Biomimetic Drugs. He finished his postdoctoral researches in Peking University, Louisiana State University, and Yale University (2003-2007). His research interests are the effective components of traditional Chinese medicines, and biosynthesis of natural products. He has published 105 papers as corresponding author, and his work has been cited for over 4000 times. His h-index is 33. He received two National Awards in 2012 (Natural Science) and 2016 (S&T Progress) for his contribution to the quality control of traditional Chinese medicine. He also received the National Science Fund for Distinguished Young Scholars in 2017. He was elected as a committee member of the Chinese Pharmacopoeia Commission in 2017. He now serves as associate editor for Journal of Ethnopharmacology and Pharmaceutical Biology, as well as editorial board member for WJTCM, JPBA, APSB, and other scientific journals.

Comments are closed.